Vadodara, January 2, 2026: Gujarat Kidney and Superspeciality Limited (BSE: 544666) has approved the acquisition of a 100 percent equity stake in Parekhs Hospital Private Limited, marking a significant expansion move in the healthcare services space. The transaction will make Parekhs Hospital a wholly owned subsidiary of the company.
The decision was cleared at the company’s board meeting held earlier today. The acquisition will be executed through a share purchase agreement with the promoter group of Parekhs Hospital and will be carried out through a cash consideration.
Deal Value and Structure
The total cost of acquisition has been fixed at ₹77 crore, under which Gujarat Kidney and Superspeciality will acquire 2,55,000 equity shares, representing full ownership of Parekhs Hospital Private Limited. The company expects the transaction to be completed within approximately two months.| Particulars | Details |
|---|---|
| Target Company | Parekhs Hospital Private Limited |
| Stake Acquired | 100 percent |
| Number of Shares | 2,55,000 equity shares |
| Mode of Payment | Cash consideration |
| Acquisition Cost | ₹77 crore |
| Expected Completion | Around 2 months |
About the Target Entity
Parekhs Hospital Private Limited is a medical and healthcare services provider incorporated on January 13, 2006, with its registered office in Ahmedabad, Gujarat. The hospital operates within India and offers specialised healthcare services.Financial Performance of Parekhs Hospital
| Financial Year | Turnover (₹ crore) |
|---|---|
| FY25 | 25.67 |
| FY24 | 26.36 |
| FY23 | 24.08 |
About the Company
Gujarat Kidney and Superspeciality Limited is a healthcare services provider focused on specialised medical treatment, particularly in kidney and super-speciality care. The company is listed on the BSE and operates from its registered office in Vadodara, Gujarat.Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.